Alterations of the Characteristics of the Circadian Rest‐Activity Rhythm of Cancer In‐Patients

The aim of the present study was to evaluate the characteristics of the circadian rest‐activity rhythm of cancer patients. Thirty‐one in‐patients, consisting of 19 males and 12 females, were randomly selected from the Regional Cancer Center, Pandit Jawaharlal Nehru Medical College, Raipur, India. The rest‐activity rhythm was studied non‐invasively by wrist actigraphy, and compared with 35 age‐matched apparently healthy subjects (22 males and 13 females). All subjects wore an Actiwatch (AW64, Mini Mitter Co. Inc., USA) for at least 4–7 consecutive days. Fifteen‐second epoch length was selected for gathering actigraphy data. In addition, several sleep parameters, such as time in bed, assumed sleep, actual sleep time, actual wake time, sleep efficiency, sleep latency, sleep bouts, wake bouts, and fragmentation index, were also recorded. Data were analyzed using several statistical techniques, such as cosinor rhythmometry, spectral analysis, ANOVA, Duncan's multiple‐range test, and t‐test. Dichotomy index (I<O) and autocorrelation coefficient (r24) were also computed. The results validated a statistically significant circadian rhythm in rest‐activity with a prominent period of 24 h for most cancer patients and control subjects. Results of this study further revealed that cancer patients do experience a drastic alteration in the circadian rest‐activity rhythm parameters. Both the dichotomy index and r24 declined in the group of cancer patients. The occurrence of the peak (acrophase, Ø) of the rest‐activity rhythm was earlier (p<0.001) in cancer patients than age‐ and gender‐matched control subjects. Results of sleep parameters revealed that cancer patients spent longer time in bed, had longer assumed and actual sleep durations, and a greater number of sleep and wake bouts compared to control subjects. Further, nap frequency, total nap duration, average nap, and total nap duration per 1 h awake span were statistically significantly higher in cancer patients than control subjects. In conclusion, the results of the present study document the disruption of the circadian rhythm in rest‐activity of cancer in‐patients, with a dampening of amplitude, lowering of mean level of activity, and phase advancement. These alterations of the circadian rhythm characteristics could be attributed to disease, irrespective of variability due to gender, sites of cancer, and timings of therapies. These results might help in designing patient‐specific chronotherapeutic protocols.

[1]  P. Andrews,et al.  Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment , 2002, Supportive Care in Cancer.

[2]  Sushmita Roy,et al.  Implications of the study of rest – activity circadian rhythm in head and neck cancer patients , 2006 .

[3]  F. Lévi,et al.  Circadian‐system alterations during cancer processes: A review , 1997, International journal of cancer.

[4]  Germaine Cornelissen,et al.  Statistical procedures in chronobiology and chronopharmacology , 1985 .

[5]  W. Hrushesky,et al.  Circadian chemotherapy for gynecological and genitourinary cancers , 2002, Chronobiology international.

[6]  Giuseppe Tonini,et al.  Cancer chronotherapy: Principles, applications, and perspectives , 2003, Cancer.

[7]  F. Lévi,et al.  Rhythm alteration in patients with metastatic breast cancer and poor prognostic factors , 2005, Journal of Cancer Research and Clinical Oncology.

[8]  Francis Lévi,et al.  Host circadian clock as a control point in tumor progression. , 2002, Journal of the National Cancer Institute.

[9]  Circadian function in patients with advanced non-small-cell lung cancer , 2005, British Journal of Cancer.

[10]  Daniel J Buysse,et al.  Age‐Related Differences in the Lifestyle Regularity of Seniors Experiencing Bereavement, Care‐Giving, Insomnia, and Advancement Into Old‐Old Age , 2006, Chronobiology international.

[11]  Sonia Ancoli-Israel,et al.  Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer , 2006, Supportive Care in Cancer.

[12]  Stefano Iacobelli,et al.  Elevated Serum Cytokines Correlated with Altered Behavior, Serum Cortisol Rhythm, and Dampened 24-Hour Rest-Activity Patterns in Patients with Metastatic Colorectal Cancer , 2005, Clinical Cancer Research.

[13]  E. McFadden,et al.  Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.

[14]  Kathryn A. Lee,et al.  Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: a pilot study. , 1999, Journal of pain and symptom management.

[15]  D. Mecke,et al.  Diminished Pineal Function Coincides with Disturbed Circadian Endocrine Rhythmicity in Untreated Primary Cancer Patients , 1994, Annals of the New York Academy of Sciences.

[16]  Kathryn A. Lee,et al.  Sleep wake disturbances in people with cancer and their caregivers: state of the science. , 2005, Oncology nursing forum.

[17]  Max Hirshkowitz,et al.  Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: an update for 2002. , 2003, Sleep.

[18]  G. Atkinson,et al.  The difference between activity when in bed and out of bed. I. Healthy subjects and selected patients. , 1996, Chronobiology international.

[19]  F Halberg,et al.  Methods for cosinor-rhythmometry. , 1979, Chronobiologia.

[20]  Ueli Schibler,et al.  Circadian rhythms: mechanisms and therapeutic implications. , 2007, Annual review of pharmacology and toxicology.

[21]  M. Mormont,et al.  Contribution of the rest–activity circadian rhythm to quality of life in cancer patients , 2002, Chronobiology international.

[22]  Francis Lévi,et al.  Chronotherapeutics: The Relevance of Timing in Cancer Therapy , 2006, Cancer Causes & Control.

[23]  J Lellouch,et al.  Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  F. Lévi,et al.  Circadian chronotherapy for human cancers. , 2001, The Lancet. Oncology.

[25]  N. Goel,et al.  Gender Differences in Polysomnographic Sleep in Young Healthy Sleepers , 2005, Chronobiology international.

[26]  F. Lévi,et al.  [Study of circadian rhythms of activity by actometry: preliminary results in 30 patients with metastatic colorectal cancer]. , 1996, Pathologie-biologie.

[27]  M. Smolensky,et al.  Ethics, Standards, and Procedures of Animal and Human Chronobiology Research , 2006, Chronobiology international.

[28]  F. Lévi,et al.  Marker rhythms of circadian system function: a study of patients with metastatic colorectal cancer and good performance status , 2002, Chronobiology international.

[29]  P. Stone,et al.  Comparison between fatigue, sleep disturbance, and circadian rhythm in cancer inpatients and healthy volunteers: evaluation of diagnostic criteria for cancer-related fatigue. , 2006, Journal of pain and symptom management.

[30]  K. Kliche,et al.  Circadian variation of dihydropyrimidine dehydrogenase mRNA expression in leukocytes and serum cortisol levels in patients with advanced gastrointestinal carcinomas compared to healthy controls , 2002, Journal of Cancer Research and Clinical Oncology.

[31]  A. Wirz-Justice,et al.  Age‐related Changes in the Circadian and Homeostatic Regulation of Human Sleep , 2006, Chronobiology international.

[32]  A. Berger,et al.  Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. , 1998, Oncology nursing forum.

[33]  F. Lévi,et al.  Chronotherapy for cancer. , 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[34]  M. Mormont,et al.  Assessment of circadian rhythms by actimetry in healthy subjects and patients with advanced colorectal cancer. , 2003, Oncology reports.